TBX21 and mature T-cell and NK-cell non-Hodgkin lymphoma: This may provide insights into the significantly better prognosis of PTCL-TBX21 cases, highlighting the need to convert the immune-excluded TME of PTCL-GATA3 into a more inflammatory one.